USSTOCK.TODAY
Pre-Market
Log in Sign up

Sarepta Therapeutics Announces Q3 2026 Results and Raises Revenue Guidance

The Motley Fool +1 · ·by G4L

SRPT
SRPT Sarepta Therapeutics Inc
$17.24 -3.25%
View chart & analysis →
  1. 1Sarepta Therapeutics reported total revenue of $381.4 million for the third quarter of 2026.
  2. 2Sarepta Therapeutics' total net product revenue for the third quarter is approximately $324 million.
  3. 3Sarepta Therapeutics raised its full-year 2026 net product revenue guidance range to $1.25 billion–$1.3 billion.

So what's the key point?

Sarepta Therapeutics generated $381.4 million in revenue in the third quarter of 2026. The company has increased its expected net product revenue for the future.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

United Therapeutics Posts Q2 Net Income of $333 Million Associated Press +1 · Aug 5Marvell Technology Proposes $115 Billion Acquisition of Lumentum The Motley Fool +1 · 3d agoCVRx lowers annual guidance as Q3 revenue hits $13.8 million The Motley Fool +1 · 3d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news